UK audit explores reasons patients skip diabetic retinopathy screenings

News
Article

Investigators emphasised the need for continued efforts to raise awareness and support patients in attending regular screening

Two elderly patients, a black woman and a white man, in a clinic support each other. Image credit: ©Seventyfour – stock.adobe.com

Addressing specific barriers can enhance screening rates, which may increase the detection of early retinopathy and improve patient outcomes. Image credit: ©Seventyfour – stock.adobe.com

A research team from England has identified factors, such as mental health issues, lack of diabetic eye screening awareness and transport difficulties, which interfere with attendance at annual screenings by patients with diabetes. The team also evaluated the adherence to guidelines set by the National Institute for Health and Care Excellence (NICE),1 according to the lead author, Upamanyu Leo Chanda, MBBS. He is from the Emergency Department, New Cross Hospital, Royal Wolverhampton Trust, Wolverhampton, England.

The investigators underscored that diabetic retinopathy is the most common sight-threatening complication of diabetes that requires regular monitoring of eyes. NICE recommends annual diabetic eye screening for patients aged 12 and older.

In light of this, the investigators conducted a retrospective clinical audit to determine why patients do not adhere to the guidelines, comparing data from about 9,000 patients.

Study methods and findings

Chanda and colleagues used the SystmOne patient database to identify patients who had missed eye screening during the previous 15 and 36 months; those in the second group were considered non-attenders.

The investigators explained, “A survey of every third patient who missed screening in the last 15 months highlighted mental health issues, lack of diabetic eye screening (DES) awareness and transport difficulties as primary reasons for non-attendance. The DES uptake rates recorded at the practice were 77.2% (n=465) for the 15-month cohort and 83.6% (n=503) for the 36-month cohort, exceeding the NHS DES target of 75%.” The authors reported their findings in Cureus.

Having identified these factors, they proposed the following actions to increase attendance among patients to DES: “telephone prompts for patients with mental health concerns, text message reminders and online educational tools to improve uptake.”

Among the factors identified, the most prevalent reasons for non-attendance were linked to mental health issues and a lack of knowledge about diabetic retinopathy. The investigators suggested that implementing targeted interventions, such as phone call prompts for patients with known mental health conditions, text message reminders preceding appointments and online educational portals, should help increase the numbers of patients who attend annual screening examinations.

The investigators also pointed out the need for continuing these efforts to raise awareness and support patients in attending regular screening. “Future re-audits following the implementation of the proposed interventions could help evaluate the impact of these strategies and provide further insights into optimising diabetic retinopathy screening in primary care practices,” they said.

“Despite standards exceeding the national guidelines, this audit demonstrates the importance of addressing specific barriers to enhance screening rates, potentially increasing the detection of early retinopathy and improving patient outcomes,” Chanda and colleagues stated.

Reference

  1. Chanda U, Madasu A, Bhardwaj A, et al. Barriers to yearly diabetic retinopathy screening attendance: a retrospective clinical audit. Cureus. 2024;16: e75474. doi:10.7759/cureus.75474; published online December 10, 2024.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
Related Content
© 2025 MJH Life Sciences

All rights reserved.